MENU
+Compare
INVA
Stock ticker: NASDAQ
AS OF
Oct 17 closing price
Price
$17.27
Change
+$0.02 (+0.12%)
Capitalization
1.09B

INVA Innoviva Forecast, Technical & Fundamental Analysis

Innoviva Inc is a company with a portfolio of royalties healthcare assets... Show more

INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for INVA with price predictions
Oct 17, 2025

INVA in downward trend: 10-day moving average broke below 50-day moving average on September 22, 2025

The 10-day moving average for INVA crossed bearishly below the 50-day moving average on September 22, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

INVA moved below its 50-day moving average on September 19, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for INVA entered a downward trend on October 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where INVA's RSI Indicator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where INVA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for INVA just turned positive on October 17, 2025. Looking at past instances where INVA's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INVA advanced for three days, in of 307 cases, the price rose further within the following month. The odds of a continued upward trend are .

INVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.523) is normal, around the industry mean (24.226). P/E Ratio (30.298) is within average values for comparable stocks, (54.529). Projected Growth (PEG Ratio) (0.203) is also within normal values, averaging (2.181). Dividend Yield (0.000) settles around the average of (0.036) among similar stocks. P/S Ratio (3.957) is also within normal values, averaging (349.660).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. INVA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

INVA is expected to report earnings to fall 37.34% to 48 cents per share on October 29

Innoviva INVA Stock Earnings Reports
Q3'25
Est.
$0.48
Q2'25
Beat
by $0.31
Q1'25
Missed
by $1.07
Q4'24
Missed
by $0.06
Q3'24
Missed
by $0.25
The last earnings report on August 04 showed earnings per share of 76 cents, beating the estimate of 46 cents. With 760.83K shares outstanding, the current market capitalization sits at 1.09B.
A.I.Advisor
published Dividends

INVA paid dividends on September 30, 2015

Innoviva INVA Stock Dividends
А dividend of $0.25 per share was paid with a record date of September 30, 2015, and an ex-dividend date of September 08, 2015. Read more...
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1350 Old Bayshore Highway
Phone
+1 650 238-9600
Employees
112
Web
https://www.inva.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OTCFX59.420.09
+0.15%
T. Rowe Price Small-Cap Stock
HDVRX15.130.01
+0.07%
Hartford International Equity R3
FIFWX26.31N/A
N/A
Fidelity Advisor Founders Z
EMREX21.19-0.03
-0.14%
JPMorgan Emerging Mkts Rsrch Enh Eq I
MSJSX19.62-0.15
-0.76%
Morgan Stanley Global Endurance R6

INVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INVA has been loosely correlated with CLDX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if INVA jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INVA
1D Price
Change %
INVA100%
+0.12%
CLDX - INVA
34%
Loosely correlated
+1.05%
DTIL - INVA
34%
Loosely correlated
+3.92%
DSGN - INVA
33%
Loosely correlated
-6.97%
ELVN - INVA
33%
Loosely correlated
-1.56%
NRIX - INVA
33%
Poorly correlated
-1.89%
More